AMENDMENT NO. 1 TO OTC LICENSE AGREEMENTOtc License Agreement • November 5th, 2009 • Santarus Inc • Pharmaceutical preparations • New York
This Amendment No. 1 (the “Amendment”) to the OTC License Agreement dated October 17, 2006 (the “License”), between Schering-Plough Healthcare Products, Inc. (“Schering”) and Santarus, Inc. (“Santarus”) is made as of July 24, 2009 (the “Effective Date”).
LICENSE AGREEMENTLicense Agreement • November 5th, 2009 • Santarus Inc • Pharmaceutical preparations • New York
This LICENSE AGREEMENT (the “Agreement”) is entered into as of the 9th day of October, 2009 (the “Effective Date”) by and between Santarus, Inc., a Delaware corporation, with its principal office at 3721 Valley Centre Drive, Suite 400, San Diego, CA 92130 (“Santarus”) and Norgine B.V., a limited liability company under the laws of the Netherlands with its principal office at Hogehilweg 7, 1101 CA Amsterdam ZO, the Netherlands (“Norgine”). Santarus and Norgine are sometimes referred to herein collectively as the “Parties” and separately as a “Party.”
